This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|July 2, 2020
- Pharmaceutical Technology-07-02-2020
- Volume 44
- Issue 7
Pharmaceutical Technology North America, July 2020 (PDF)
Click the title above to open the Pharmaceutical Technology July 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Qualification of a Swab-Sampling Procedure for Cleaning Validationabout 6 years ago
Performing Remote Audits During the Pandemicabout 6 years ago
Demand for Custom Dosage Forms Fuels Innovationabout 6 years ago
Learning Regulatory Lessons in Times of a Crisisabout 6 years ago
Business on Hold? EMA’s Full Recovery in Questionabout 6 years ago
Taking a Controlled Approachabout 6 years ago
Unprecedented Times in Vaccinesabout 6 years ago
No Business, Like Brexit Businessabout 6 years ago
Innovating Continuous Twin-Screw Granulation with Foam DeliveryAdvertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement